Jason J. Luke, MD, FACP, an associate professor of medicine in the Division of Hematology/Oncology and director of the Cancer Immunotherapeutics Center within the Immunology and Immunotherapy Program at the University of Pittsburgh Medical Center Hillman Cancer Center, discussed the future of T-cell therapies in melanoma, emerging biomarkers, and ongoing research regarding the gut microbiome, in an extended interview.

Learn more by clicking here.